During study startup, clinical trials sponsors must balance study enrollment targets and expectations with the capabilities delivered by global sites. Beyond the traditional challenges that companies face with enrollment, Amgen also had to navigate issues created by the COVID-19 global pandemic that impacted daily activities and enrollment in clinical studies.
Amgen, one of the world’s largest independent biopharmaceutical companies, has adopted use of StudyTeam across their entire global research portfolio.
StudyTeam provides cloud-based software that accelerates the development of new and life-saving therapies. We serve the global life science industry, including thousands of clinical research sites, the most innovative biotechs, and the world's largest biopharmaceutical companies.
Play the video to hear how StudyTeam can help you speed up enrollment.
OneStudyTeam, a member of the Reify Health portfolio, provides the cloud-based platform StudyTeam to accelerate the development of new and life-saving therapies. StudyTeam brings research site workflows online and enables sites, sponsors, and other key stakeholders to work together more effectively using common technology. The suite of StudyTeam solutions reduces site burden and helps sites pre-screen and enroll more patients, provides sponsors with end-to-end visibility into recruitment activity across all channels, and guides sites in conducting the trial for patients who have been enrolled. StudyTeam is trusted by the largest global biopharmaceutical companies, used in more than 6,000 research sites, and is available in over 100 countries.
One mission. One team. That’s OneStudyTeam.
33 Arch Street 17th Floor Boston, MA 02110
Join Our Mailing List
Get OneStudyTeam news and clinical trial enrollment insights delivered directly to your inbox.
Copyright © 2024 OneStudyTeam, Inc. All Rights Reserved.